An Update on Machine Learning in Neuro-Oncology Diagnostics
Imaging biomarkers in neuro-oncology are used for diagnosis, prognosis and treatment response monitoring. Magnetic resonance imaging is typically used throughout the patient pathway because routine structural imaging provides detailed anatomical and pathological information and advanced techniques provide additional physiological detail.
Following image feature extraction, machine learning allows accurate classification in a variety of scenarios. Machine learning also enables image feature extraction de novo although the low prevalence of brain tumours makes such approaches challenging.
Much research is applied to determining molecular profiles, histological tumour grade and prognosis at the time that patients first present with a brain tumour. Following treatment, differentiating a treatment response from a post-treatment related effect is clinically important and also an area of study. Most of the evidence is low level having been obtained retrospectively and in single centres.
KeywordsNeuro-oncology Machine learning Diagnostic
This work was supported by the Wellcome/EPSRC Centre for Medical Engineering [WT 203148/Z/16/Z].
- 1.FDA-NIH Biomarker Working Group: BEST (Biomarkers, EndpointS, and other Tools) Resource. Food and Drug Administration (US), Silver Spring. Co-published by National Institutes of Health (US), Bethesda (2016)Google Scholar
- 3.Wen, P.Y., Macdonald, D.R., Reardon, D.A., Cloughesy, T.F., Sorensen, A.G., Galanis, E.: Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J. Clin. Oncol. 28, 1963–1972 (2010). https://doi.org/10.1200/JCO.2009.26.3541CrossRefGoogle Scholar
- 6.Howick, J., et al.: OCEBM Table of Evidence Working Group: The Oxford 2011 Levels of Evidence (2011). http://www.cebm.net/index.aspx?o=5653. Oxford Centre for Evidence-Based Medicine, Oxford (2016)
- 12.Kebir, S., et al.: Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high grade glioma. Oncotarget 8(5), 8294–8304 (2016)Google Scholar
- 14.Chato, L., Latifi, S.: Machine learning and deep learning techniques to predict overall survival of brain tumor patients using MRI images. In: 17th IEEE International Conference on Bioinformatics and Engineering. IEEE Press, New York (2017). https://doi.org/10.1109/bibe.2017.00009